The role of gut hormones in glucose homeostasis

gan Drucker, Daniel J.
Cyhoeddwyd 2007

Incretin-Based Therapy and the Quest for Sustained Improvements in β-Cell Health

gan Drucker, Daniel J.
Cyhoeddwyd 2011

Essay for the 2011 CIHR/CMAJ award: glucagon-like peptides for metabolic and gastrointestinal disorders

gan Drucker, Daniel J.
Cyhoeddwyd 2012

Incretin Action in the Pancreas: Potential Promise, Possible Perils, and Pathological Pitfalls

gan Drucker, Daniel J.
Cyhoeddwyd 2013

The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome

gan Drucker, Daniel J.
Cyhoeddwyd yn ACS Pharmacol Transl Sci (2019)

Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications

gan Drucker, Daniel J
Cyhoeddwyd yn Endocr Rev (2020)

Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning

gan Drucker, Daniel J.
Cyhoeddwyd yn Cell Metab (2021)

Cardiovascular Biology of the Incretin System

gan Ussher, John R., Drucker, Daniel J.
Cyhoeddwyd 2012

Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight

gan Baggio, Laurie L., Drucker, Daniel J.
Cyhoeddwyd 2014

Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors

gan Mulvihill, Erin E., Drucker, Daniel J.
Cyhoeddwyd yn Endocr Rev (2014)

Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease

gan Baggio, Laurie L., Drucker, Daniel J.
Cyhoeddwyd yn Mol Metab (2020)

Lipid Raft-dependent Glucagon-like Peptide-2 Receptor Trafficking Occurs Independently of Agonist-induced Desensitization

gan Estall, Jennifer L., Yusta, Bernardo, Drucker, Daniel J.
Cyhoeddwyd 2004

GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms

gan Flock, Grace, Holland, Dianne, Seino, Yutaka, Drucker, Daniel J.
Cyhoeddwyd 2010

Discovery, characterization, and clinical development of the glucagon-like peptides

gan Drucker, Daniel J., Habener, Joel F., Holst, Jens Juul
Cyhoeddwyd yn J Clin Invest (2017)

Exendin-4 Modulates Diabetes Onset in Nonobese Diabetic Mice

gan Hadjiyanni, Irene, Baggio, Laurie L., Poussier, Philippe, Drucker, Daniel J.
Cyhoeddwyd 2008

Intestinotrophic Glucagon-Like Peptide-2 (GLP-2) Activates Intestinal Gene Expression and Growth Factor-Dependent Pathways Independent of the Vasoactive Intestinal Peptide Gene in...

gan Yusta, Bernardo, Holland, Dianne, Waschek, James A., Drucker, Daniel J.
Cyhoeddwyd 2012

Activation of Enteroendocrine Membrane Progesterone Receptors Promotes Incretin Secretion and Improves Glucose Tolerance in Mice

gan Flock, Grace B., Cao, Xiemin, Maziarz, Marlena, Drucker, Daniel J.
Cyhoeddwyd 2013

Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis

gan Ali, Safina, Lamont, Benjamin J., Charron, Maureen J., Drucker, Daniel J.
Cyhoeddwyd 2011

Brain GLP-1 Signaling Regulates Femoral Artery Blood Flow and Insulin Sensitivity Through Hypothalamic PKC-δ

gan Cabou, Cendrine, Vachoux, Christelle, Campistron, Gérard, Drucker, Daniel J., Burcelin, Rémy
Cyhoeddwyd 2011

Glucagon-like Peptide-2 Does Not Modify the Growth or Survival of Murine or Human Intestinal Tumor Cells

gan Koehler, Jacqueline A., Harper, Will, Barnard, Maja, Yusta, Bernardo, Drucker, Daniel J.
Cyhoeddwyd 2008